Burnham Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Burnham Asset Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$4.01M	Buy	11,475 +6,450	+128%	+$2.48M	1.12%	22
2016 Q1	$1.81M	Sell	5,025 -9,125	-64%	-$3.76M	0.57%	52
2015 Q4	$7.68M	Hold	14,150	–	–	2.1%	5
2015 Q3	$6.58M	Hold	14,150	–	–	1.74%	9
2015 Q2	$7.22M	Hold	14,150	–	–	1.67%	8
2015 Q1	$6.39M	Buy	14,150 +50	+0.4%	+$21.2K	1.46%	10
2014 Q4	$5.79M	Hold	14,100	–	–	1.31%	12
2014 Q3	$5.08M	Sell	14,100 -100	-0.7%	-$33.5K	1.12%	21
2014 Q2	$4.01M	Buy	14,200 +400	+3%	+$119K	0.88%	28
2014 Q1	$4.14M	Buy	13,800 +3,600	+35%	+$1.11M	0.98%	23
2013 Q4	$2.81M	Buy	10,200 +200	+2%	+$57.5K	0.66%	43
2013 Q3	$3.13M	Hold	10,000	–	–	0.78%	36
2013 Q2	$2.25M	Buy	+10,000	New	+$2.33M	0.57%	54

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Burnham Asset Management's REGN Position: Q2 2016 in Review

Burnham Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 128% in Q2 2016, buying an estimated $2.48M and bringing the position to 11,475 shares worth $4.01M. The position accounts for 1.12% of the portfolio, ranked #22.

Burnham Asset Management first reported a position in REGN in Q2 2013 and has held it in 13 quarters since. The position peaked at $7.68M in Q4 2015. 541 funds tracked by Wall St. Rank hold REGN as of Q2 2016.

Burnham Asset Management held 11,475 shares of Regeneron Pharmaceuticals worth $4.01M as of Q2 2016.
Burnham Asset Management bought 6,450 Regeneron Pharmaceuticals shares in Q2 2016, an estimated $2.48M.
Regeneron Pharmaceuticals made up 1.12% of Burnham Asset Management's portfolio in Q2 2016, its #22 holding.
Burnham Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 13 quarters since.
Burnham Asset Management's Regeneron Pharmaceuticals position peaked at $7.68M in Q4 2015.
541 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2016.

Based on Burnham Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.